| Name | Title | Contact Details |
|---|
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.
Founded in 2019, Wellvana is a company designed to support independent physicians and help them thrive in their transition to value-based care. With a mission of creating a national footprint of high performing, locally narrow networks, Wellvana aims to deliver high quality and highly efficient healthcare services while contracting on behalf of and migrating physicians towards risk-based reimbursement methodologies. Wellvana provides the resources, experience, and leadership to allow physicians to practice effectively, achieve work life balance, and benefit from risk-based revenue models, while respecting cultural, regional, and individual practice uniqueness.
Revolution Health Group LLC is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.
The mission of Life Line Screening is to make people aware of an undetected health problem and encourage them to seek follow up care with their physician. We are dedicated to providing the highest quality preventive screenings at an affordable rate.